Stereotactic ablative radiotherapy (SABR) for recurrent and previously irradiated head and neck cancers

OBJECTIVE: To assess the response and toxicity of stereotactic ablative radiotherapy (SABR) in patients with recurrent head and neck cancer (HNC), who had previously received radiation for their primary tumor. METHODS: Between 2014 and 2018, patients who received SABR to recurrent HNC within the pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Anand, Anil Kumar, Dua, Bharat, Bansal, Anil Kumar, Singh, Heigrujam Malhotra, Verma, Amit, Kumar, Amit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Institute of Radiology. 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594905/
https://www.ncbi.nlm.nih.gov/pubmed/33178969
http://dx.doi.org/10.1259/bjro.20190051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594905/
https://www.ncbi.nlm.nih.gov/pubmed/33178969
http://dx.doi.org/10.1259/bjro.20190051

Ejemplares similares